No Data
Express News | Neurocrine Biosciences Inc : JP Morgan Raises Target Price to $173 From $169
Jefferies Maintains Neurocrine Biosciences(NBIX.US) With Buy Rating, Cuts Target Price to $175
Jefferies analyst Akash Tewari maintains $Neurocrine Biosciences(NBIX.US)$ with a buy rating, and adjusts the target price from $182 to $175.According to TipRanks data, the analyst has a success
Express News | Neurocrine Biosciences Inc : RBC Cuts Target Price to $136 From $141
RBC Cuts Price Target on Neurocrine Biosciences to $136 From $141, Keeps Sector Perform Rating
Neurocrine Biosciences (NBIX) has an average investment rating of outperform among analysts polled by Capital IQ, with price targets ranging from $111 to $216.
Neurocrine Biosciences Insider Sold Shares Worth $1,401,864, According to a Recent SEC Filing
Julie Cooke, Chief Human Resources Officer, on July 01, 2024, sold 10,000 shares in Neurocrine Biosciences (NBIX) for $1,401,864. Following the Form 4 filing with the SEC, Cooke has control over a tot
Neurocrine Biosciences(NBIX.US) Officer Sells US$1.4 Million in Common Stock
$Neurocrine Biosciences(NBIX.US)$ Officer Cooke Julie sold 10,000 shares of common stock on Jul 1, 2024 at an average price of $140.1864 for a total value of $1.4 million.Source: Announcement What is